Skip to main content
ZDZT logo

Zhengduozhe Technology Inc. (ZDZT) Stock Price & Analysis

Zhengduozhe Technology Inc. (ZDZT) — price $0.5502 (0.00%), as of the Nov 19, 2026 trading session.

Educational signal · not a buy or sell recommendation · How to read this

$0.5502 $0.00 (0.00%)

Zhengduozhe Technology Inc. · ZDZT

Zhengduozhe Technology Inc., operating as DAKOTA Life Sciences, focuses on acquiring, developing, and commercializing pharmaceuticals. The company aims to provide affordable solutions for antimicrobial resistance in hospital and community settings.

Price as of Nov 19, 2026

Key Statistics

Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.

Thousands of the 20,000+ US stocks here carry a MoonshotScore.

Scored companies in the same industry:

  • MTRI · Metro Inc. · 38 /100
  • DMII · Drugs Made In America Acquisition II Corp. · 49 /100
  • BCSS · Bain Capital GSS Investment Cor · 55 /100

See all scored stocks →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.5502
Change on the day0.00%
52-week range$0.5485 – $1.18
Shares traded on the day1

Price & events

1 · What is it?

What is Zhengduozhe Technology (ZDZT), and what does it report?

Short answer · as of

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Zhengduozhe Technology Inc. (ZDZT) is the company analyzed here. It is led by Jingwei Zhang. In Q3 FY2025 it reported revenue of $85,830 and net income of -$2M.

2 · Latest results

What do the latest results show for Zhengduozhe Technology (ZDZT)?

Short answer · as of

The most recent reported quarter, Q3 FY2025, carried revenue of $85,830.

Quarterly income statement — 1 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2025$85,830-$2M-$1.21 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Zhengduozhe Technology (ZDZT)?

Short answer · as of

The distress and quality screens read Altman Z -4.40 · Piotroski F 1. Trailing ratios: ROA -48.8% · current ratio 0.14.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of -4.40 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.

The records behind this page

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ZDZT in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ZDZT in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

Common Questions About ZDZT

These answers are editorial: 1 of these 8 answers is drawn from the ZDZT research dossier (written Mar 17, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.

Is ZDZT a good stock to buy?

Stock Expert AI does not rate ZDZT buy, sell or hold. Zhengduozhe Technology Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ZDZT stock price today?

The last price recorded for Zhengduozhe Technology Inc. (ZDZT), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What are the main risks for ZDZT?

The main risks for Zhengduozhe Technology Inc. include regulatory hurdles, competition from established pharmaceutical companies, potential drug failures, limited financial resources, and high investor expectations.

What are the key factors to evaluate for ZDZT?

Evaluate ZDZT on fundamentals, analyst consensus, and risk factors. Not financial advice.

How frequently does ZDZT data refresh on this page?

ZDZT's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ZDZT's recent stock price performance?

Zhengduozhe Technology Inc. (ZDZT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on addressing antimicrobial resistance. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ZDZT overvalued or undervalued right now?

Zhengduozhe Technology Inc. (ZDZT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research ZDZT before investing?

Before investing in Zhengduozhe Technology Inc. (ZDZT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 11 figures on this page — 7 from Financial Modeling Prep (FMP) and 4 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.